These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9558621)

  • 1. [Cefotaxime: current status and future prospectives after 15 years of experience].
    García-Rodríguez JA; García Sánchez JE; García Sánchez E; Fresnadillo MJ
    Rev Clin Esp; 1996 Jul; 196 Suppl 2():67-73. PubMed ID: 9558621
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
    Ko WC; Lee HC; Chuang YC; Ten SH; Su CY; Wu JJ
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1281-3. PubMed ID: 11257047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefotaxime in dialysis patients.
    Andrassy K
    Diagn Microbiol Infect Dis; 1995; 22(1-2):85-7. PubMed ID: 7587055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime for the 1990s.
    Lode H
    Diagn Microbiol Infect Dis; 1995; 22(1-2):1-3. PubMed ID: 7587021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathomorphological changes in albino mice infected with plague and treated with cefotaxime].
    Makarovskaia LN; Sorokina TB; Zurabian VA; Ryzhkova VV; Markovskaia EI
    Antibiot Khimioter; 1998; 43(3):27-30. PubMed ID: 9606494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Meningitis by Streptococcus pneumoniae: resistant to cefotaxime?].
    Fernández-Fernández FJ; García-Rodríguez JF; Sesma P; González-González C
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):45-6. PubMed ID: 10069118
    [No Abstract]   [Full Text] [Related]  

  • 7. Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
    Prabha Adhikari MR; Baliga S
    J Assoc Physicians India; 2002 Mar; 50():428-9. PubMed ID: 11924574
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cefotaxime in sequential therapy of community acquired pneumonia].
    Wolska-Goszka L; Petlak A; Słomiński JM
    Pol Merkur Lekarski; 1999 Sep; 7(39):99-101. PubMed ID: 10598482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Empirical treatment with cephotaxim in Echovirus type 3 meningitis].
    Hortelano López M; Herrera Martín M; Cuadrado Bello P
    An Esp Pediatr; 1997 Nov; 47(5):550. PubMed ID: 9586304
    [No Abstract]   [Full Text] [Related]  

  • 10. [Elective treatment in meningitis due to Neisseria meningitidis].
    Quiles Durá JL
    An Esp Pediatr; 1998 Aug; 49(2):210. PubMed ID: 9773566
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of cefotaxime in brain abscess.
    Donald FE; Ispahani P
    Br J Neurosurg; 1988; 2(4):539-40. PubMed ID: 3267340
    [No Abstract]   [Full Text] [Related]  

  • 12. [The usefulness of the disk diffusion method for evaluation of the sensitivity of Neisseria meningitidis to penicillin and cefotaxime].
    Campos J
    Enferm Infecc Microbiol Clin; 1998; 16(7):347-9. PubMed ID: 9808892
    [No Abstract]   [Full Text] [Related]  

  • 13. Albumin: a look at the evidence.
    Basta SA; Oldfield EC
    Am J Gastroenterol; 2001 Mar; 96(3):916-7. PubMed ID: 11280580
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined cefotaxime and amikacin for immunomodulation in the treatment of actinomycetoma resistant to conventional treatment].
    Méndez-Tovar LJ; Serrano-Jaén L; Almeida-Arvizu VM
    Gac Med Mex; 1999; 135(5):517-21. PubMed ID: 10596493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
    Chuang YM; Tseng SP; Teng LJ; Ho YC; Hsueh PR
    J Infect; 2006 Sep; 53(3):e161-3. PubMed ID: 16375973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime in the 90's: A workshop for appropriate broad-spectrum cephalosporin utilization.
    Diagn Microbiol Infect Dis; 1995; 22(1-2):1-247. PubMed ID: 7587020
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
    Klimberg IW; Malek GH; Cox CE; Patterson AL; Whalen E; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():77-84. PubMed ID: 10225576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of ascitic fluid polymorphonuclear cell count determination during therapy of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Ljubicic N; Spajic D; Vrkljan MM; Altabas V; Doko M; Zovak M; Gacina P; Mihatov S
    Hepatogastroenterology; 2000; 47(35):1360-3. PubMed ID: 11100352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cefotaxime on cytokine production in newborns and adults in vitro.
    Bessler H; Gurary N; Aloni D; Vishne TH; Sirota L
    Biomed Pharmacother; 2000 Aug; 54(7):410-4. PubMed ID: 10989981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
    García-Contreras F; Del-Angel-García G; Ramírez Cuenca A; Malváez-Valdes M; Vega Yáñez A; Amato D
    Rev Invest Clin; 2000; 52(4):418-26. PubMed ID: 11061104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.